We report our experience with pulmonary autograft replacement of the mitral valve in eight patients. Hospital mortality of 0% was reported, and there has been one autograft failure requiring replacement (mean follow-up 12 ± 6 months). We also review the world's experience with this technique. Mitral valve replacement with a pulmonary autograft (Ross II) is safe, reproducible, and possible warranted for selected patients.
- Mitral valve replacement
- Pulmonary autograft
- Ross procedure
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Pediatrics, Perinatology, and Child Health